Safety and Efficacy of Low-Dose Metronomic Capecitabine in the Treatment of Elderly Patients with Breast Cancer: Report of Two Cases and Literature Review
Capecitabine, a 5-fluorouracil prodrug, is increasingly used in breast cancer due to its more convenient oral route of administration compared to 5-fluorouracil. Despite its widespread use, there are only a few reports on low-dose efficacy, while the clinical significance of such agents remains to b...
Main Authors: | Chao Tian, Hui Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)
2016-03-01
|
Series: | International Journal of Gerontology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873959816000144 |
Similar Items
-
Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer
by: Xue-Lian Chen, et al.
Published: (2016-04-01) -
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database
by: Qiao Yu, et al.
Published: (2023-01-01) -
Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
by: Aboelnaga Engy M, et al.
Published: (2021-08-01) -
Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
by: Giovanni Brandi, et al.
Published: (2018-06-01) -
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial
by: Maiyue He, et al.
Published: (2023-12-01)